These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28299999)

  • 1. [Not Available].
    Muheim L
    Praxis (Bern 1994); 2017; 106(6):328-329. PubMed ID: 28299999
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the risk of adverse events between risperidone and haloperidol in delirium patients.
    Miyaji S; Yamamoto K; Hoshino S; Yamamoto H; Sakai Y; Miyaoka H
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):275-82. PubMed ID: 17472596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged delirium managed with risperidone.
    Bourgeois JA; Hilty DM
    Psychosomatics; 2005; 46(1):90-1. PubMed ID: 15765831
    [No Abstract]   [Full Text] [Related]  

  • 4. A double-blind trial of risperidone and haloperidol for the treatment of delirium.
    Han CS; Kim YK
    Psychosomatics; 2004; 45(4):297-301. PubMed ID: 15232043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delirium in hospitalized patients: Risks and benefits of antipsychotics.
    Thom RP; Mock CK; Teslyar P
    Cleve Clin J Med; 2017 Aug; 84(8):616-622. PubMed ID: 28806160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotics for the treatment of delirious elders.
    Ozbolt LB; Paniagua MA; Kaiser RM
    J Am Med Dir Assoc; 2008 Jan; 9(1):18-28. PubMed ID: 18187109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects.
    Boettger S; Jenewein J; Breitbart W
    Palliat Support Care; 2015 Aug; 13(4):1079-85. PubMed ID: 25191793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
    Sikich L; Hamer RM; Bashford RA; Sheitman BB; Lieberman JA
    Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
    Möller HJ; Riedel M; Jäger M; Wickelmaier F; Maier W; Kühn KU; Buchkremer G; Heuser I; Klosterkötter J; Gastpar M; Braus DF; Schlösser R; Schneider F; Ohmann C; Riesbeck M; Gaebel W
    Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on Nasrallah et al: lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol.
    Blazer DG
    Am J Geriatr Psychiatry; 2004; 12(6):658-9; author reply 659-60. PubMed ID: 15545335
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacovigilance in hospice/palliative care: net effect of haloperidol for delirium.
    Crawford GB; Agar M M; Quinn SJ; Phillips J; Litster C; Michael N; Doogue M; Rowett D; Currow DC
    J Palliat Med; 2013 Nov; 16(11):1335-41. PubMed ID: 24138282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers.
    Artaloytia JF; Arango C; Lahti A; Sanz J; Pascual A; Cubero P; Prieto D; Palomo T
    Am J Psychiatry; 2006 Mar; 163(3):488-93. PubMed ID: 16513871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A biological basis for the sex bias of antipsychotic drugs adverse events.
    Gurwitz D; Morag A; Oved K
    J Am Geriatr Soc; 2013 Aug; 61(8):1437. PubMed ID: 23937507
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurologic side effects in neuroleptic-naïve patients treated with haloperidol or risperidone.
    Meibach RC
    Neurology; 2000 Oct; 55(7):1069. PubMed ID: 11061283
    [No Abstract]   [Full Text] [Related]  

  • 15. Risperidone-induced neutropenia: an adverse side-effect in the palliative management of delirium in a patient with lymphoma.
    Farrell H; Eastman P
    BMJ Support Palliat Care; 2013 Mar; 3(1):4-5. PubMed ID: 24644317
    [No Abstract]   [Full Text] [Related]  

  • 16. Antipsychotics and dopamine transporter gene polymorphisms in delirium patients.
    Kim JY; Jung IK; Han C; Cho SH; Kim L; Kim SH; Lee BH; Lee HJ; Kim YK
    Psychiatry Clin Neurosci; 2005 Apr; 59(2):183-8. PubMed ID: 15823165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia.
    Kane JM; Potkin SG; Daniel DG; Buckley PF
    J Clin Psychiatry; 2011 Feb; 72(2):194-204. PubMed ID: 20673553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotics Worsen Symptoms in Patients with Delirium Who Receive Palliative Care.
    Shrikant Kulkarni N
    Am Fam Physician; 2017 Mar; 95(6):Online. PubMed ID: 28318205
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of risperidone in delirium: case reports.
    Sipahimalani A; Masand PS
    Ann Clin Psychiatry; 1997 Jun; 9(2):105-7. PubMed ID: 9242897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuation of risperidone, olanzapine, and haloperidol in first-episode psychosis.
    Shim JC; Choe BM; Kim JG; Jae YM; Kim HC; Kim SG; Oh MK; Kelly DL; Conley RR
    J Clin Psychopharmacol; 2007 Aug; 27(4):400-1. PubMed ID: 17632229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.